
Genetic Mutation Testing
Genetic mutation testing in India for tumour profiling or hereditary cancer assessment, with targeted or NGS testing, molecular-pathology interpretation and genetic counselling when indicated.
Related Conditions
Our services are FREE and by using our services your hospital bill does not increase!
About Genetic Mutation Testing
Genetic mutation testing in India can refer to two distinct pathways: tumour molecular profiling for acquired cancer alterations and germline genetic testing for inherited variants that may increase cancer risk. The correct test depends on the clinical question, cancer type, pathology, family history and whether results are intended to guide treatment, hereditary-risk assessment or family counselling.
For cancer-treatment planning, specialists may analyse tumour tissue or blood using IHC, FISH, PCR, next-generation sequencing (NGS) or other validated molecular methods, depending on the tumour and biomarker. A liquid biopsy can be useful in selected settings when tissue is unavailable or when resistance testing is clinically relevant, but it does not replace tissue pathology in every case. When hereditary cancer is suspected, pre- and post-test genetic counselling is important because germline findings can affect relatives as well as the patient.
Not every detected alteration changes treatment. Results must be interpreted alongside histology, stage, previous therapy and current clinical evidence. Variants of uncertain significance should not be treated as actionable findings without appropriate expert interpretation, and broad panels can identify incidental or hereditary findings that require careful counselling.
The cost of genetic mutation testing in India depends on tumour versus germline testing, single-gene or focused panels versus broad NGS, tissue preparation, sequencing platform, pathology review, liquid-biopsy requirements and whether genetic counselling is included. Any targeted or systemic cancer therapy selected from the result is a separate treatment cost.
Leading tertiary cancer centres in India provide molecular pathology, clinical genetics and multidisciplinary oncology review. Medical Help India is a connection platform and can connect international patients with an appropriate healthcare partner to review existing pathology and molecular reports, determine whether additional testing is clinically useful and obtain an individual diagnostic estimate.
What's Included
Why consider treatment in India?
Access to experienced specialists
Advanced treatment and diagnostic options
More affordable hospital care
Shorter waiting times for treatment
Help comparing hospitals, plans and costs
Support with appointments, travel and follow-up
Cost in India
USDFinal costs depend on the medical assessment, hospital, room category and clinical needs.
How it works
Share your details
Tell us about your health concerns, age and current location.
Receive a call
We call you to discuss your situation, needs and questions.
Receive a treatment plan
Get information about the most suitable treatment plan, hospital and estimated cost.
Choose your plan
Review the options and agree on your care and travel plan.
Get full support
Receive full support throughout every stage of your care journey.
Receive care in India
Receive your planned care with support throughout your stay.
Top Hospitals for Genetic Mutation Testing
View All Hospitals →Top Doctors for Genetic Mutation Testing
View All Doctors →Frequently Asked Questions
How much does Genetic Mutation Testing cost in India?
Cost depends on whether testing is tumour or germline, a single gene or focused panel versus broad NGS, tissue preparation, sequencing platform, liquid biopsy when indicated, pathology review and genetic counselling. Any targeted or systemic treatment selected from the result is a separate treatment cost.
Which medical reports are useful to have ready for Genetic Mutation Testing?
Have ready: the pathology report and, for tumour testing, details of the available tissue block or slides plus all previous biomarker and molecular reports. Include the cancer type and stage, latest oncology notes, previous treatments and relevant family cancer history; for hereditary testing, include any prior germline reports from the patient or affected relatives when available.
Is tumour mutation testing the same as hereditary genetic testing?
No. Tumour testing looks mainly for acquired cancer changes, while germline testing looks for inherited variants that can have implications for the patient and relatives.
Does every mutation found have a targeted treatment?
No. A detected variant may be actionable, non-actionable or of uncertain significance and must be interpreted in the context of the cancer and current evidence.
Can existing molecular test results be reviewed?
Yes. An oncology or molecular-pathology team can review the original pathology and molecular report before deciding whether additional testing is useful.

Our services are FREE
We connect you with leading hospitals and specialists in India. You pay the hospital directly.


